WO2010108008A3 - Bsc cell differentiation and use in therapy - Google Patents

Bsc cell differentiation and use in therapy Download PDF

Info

Publication number
WO2010108008A3
WO2010108008A3 PCT/US2010/027824 US2010027824W WO2010108008A3 WO 2010108008 A3 WO2010108008 A3 WO 2010108008A3 US 2010027824 W US2010027824 W US 2010027824W WO 2010108008 A3 WO2010108008 A3 WO 2010108008A3
Authority
WO
WIPO (PCT)
Prior art keywords
cells
bsc
progenitor
neural
novel
Prior art date
Application number
PCT/US2010/027824
Other languages
French (fr)
Other versions
WO2010108008A2 (en
Inventor
Laura Menendez
Stephen Dalton
Original Assignee
University Of Georgia Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Georgia Research Foundation filed Critical University Of Georgia Research Foundation
Publication of WO2010108008A2 publication Critical patent/WO2010108008A2/en
Publication of WO2010108008A3 publication Critical patent/WO2010108008A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to the discovery of a novel multipotent progenitor cell termed pre-rosette stage ectoderm progenitor cells or BSC cells. These cells may be isolated, grown stably for a number of which are novel, self-renewing early ectodermal cell types (pre-rosette stage ectoderm progenitors) exhibiting neural progenitor-like characteristics generations and cryopreserved for stable storage. These cells may be further differentiated into neural cells such as neurons and glia cells, and other cells including neural crest derivative cells, among others, which may be used for transplantation and other therapies. Methods of producing these cells from BSC cells are also disclosed.
PCT/US2010/027824 2009-03-18 2010-03-18 Bsc cell differentiation and use in therapy WO2010108008A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21036509P 2009-03-18 2009-03-18
US61/210,365 2009-03-18

Publications (2)

Publication Number Publication Date
WO2010108008A2 WO2010108008A2 (en) 2010-09-23
WO2010108008A3 true WO2010108008A3 (en) 2011-03-24

Family

ID=42740232

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/027824 WO2010108008A2 (en) 2009-03-18 2010-03-18 Bsc cell differentiation and use in therapy

Country Status (1)

Country Link
WO (1) WO2010108008A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11261425B2 (en) 2009-08-12 2022-03-01 Kyoto University Method for inducing differentiation of pluripotent stem cells into neural precursor cells
CA2770753C (en) * 2009-08-12 2019-01-15 Kyoto University Method for inducing differentiation of pluripotent stem cells into neural precursor cells
EP2658966B1 (en) 2010-12-31 2017-04-05 University of Georgia Research Foundation, Inc. Differentiation of human pluripotent stem cells to multipotent neural crest cells
CN102228016B (en) * 2011-04-18 2012-07-18 上海安集协康生物技术有限公司 Cryopreservation and resuscitation method of neural stem cells
TWI493034B (en) * 2011-12-14 2015-07-21 Nat Univ Chung Hsing Neuronal epithelial cells differentiated by universal stem cells and the medium used and their differentiation methods
CA2920287C (en) * 2013-08-06 2022-03-08 Takeda Pharmaceutical Company Limited Method for producing dopaminergic neurons
MX2020005668A (en) 2017-11-30 2020-11-24 Univ Kyoto Method for culture of cells.

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ABRANCHES, E. ET AL.: "Neural differentiation of embryonic stem cells in vitro: a road map to neurogenesis in the embryo. e6286", PLOS ONE, vol. 4, no. ISS.7, July 2009 (2009-07-01), pages 1 - 14 *
BAJPAI, R. ET AL.: "Molecular stages of rapid and uniform neuralization of human embryonic stem cells.", CELL DEATH AND DIFFERENTIATION, vol. 16, 13 March 2009 (2009-03-13), pages 807 - 825 *
LEE, G. ET AL.: "Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells.", NATURE BIOTECHNOLOGY, vol. 25, no. 12, 2007, pages 1468 - 1475 *
PANKRATZ, M. ET AL.: "Directed neural differentiation of human embryonic stem cells an obligated primitive anterior stage.", STEM CELLS, vol. 25, 2007, pages 1511 - 1520 *
WILSON, P. G. ET AL.: "Development and differentiation of neural rosettes derived from human embryonic stem cells.", STEM CELL REV., vol. 2, 2006, pages 67 - 77 *

Also Published As

Publication number Publication date
WO2010108008A2 (en) 2010-09-23

Similar Documents

Publication Publication Date Title
WO2010108005A3 (en) Novel neural progenitors from pluripotent stem cells, methods of producing same and use to produce neural cells
WO2010108008A3 (en) Bsc cell differentiation and use in therapy
WO2008150814A8 (en) Methods for production and uses of multipotent cell populations
WO2012021845A3 (en) Improved hematopoietic stem and progenitor cell therapy
WO2010011352A3 (en) Compositions for mesoderm derived isl1+ multipotent cells (imps), epicardial progenitor cells (epcs) and multipotent cxcr4+cd56+ cells (c56cs) and methods of use
WO2012135621A3 (en) Priming of pluripotent stem cells for neural differentiation
WO2012048010A3 (en) Compositions of adult organ stem cells and uses thereof
WO2007100692A3 (en) Method of generating human retinal progenitors from embryonic stem cells
WO2010062911A3 (en) Compositions and methods of functionally enhanced in vitro cell culture system
NZ709124A (en) Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same
WO2009137624A3 (en) Hemangio colony forming cells and non-engrafting hemangio cells
WO2008118392A3 (en) Synthetic cell platforms and methods of use thereof
MX2009014273A (en) Methods and compositions for optimized expansion and implantation of mesenchymal stem cells.
WO2006072016A3 (en) Methods for regulation of stem cells
WO2008148105A8 (en) Endometrial stem cells and methods of making and using same
WO2012030539A3 (en) Differentiation of human embryonic stem cells
WO2012026712A3 (en) Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with nod2 agonist or cultured product thereof
WO2006047743A3 (en) Swine multipotent adult progenitor cells
NZ630598A (en) Method of engrafting cells from solid tissues
WO2012091978A3 (en) Differentiation of human pluripotent stem cells to multipotent neural crest cells
WO2013033308A3 (en) Methods for tissue culture and transformation of sugarcane
WO2008144580A3 (en) Primate stem cells produced by somatic cell nuclear transfer
WO2011112732A3 (en) Methods of treating vascular inflammatory disorders
WO2014204806A3 (en) Adipose cells for chondrocyte applications
WO2012075462A3 (en) Methods and compositions for treatment of muscular dystrophy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10754113

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10754113

Country of ref document: EP

Kind code of ref document: A2